Retina Associates of Utah

Clinical research site in Salt Lake City, Utah · 5169 COTTONWOOD ST STE 630, SALT LAKE CITY, UT 84107-6771 · (801) 281-3030 · Website

As of July 2026, 8 paid clinical trials are recruiting at Retina Associates of Utah in Salt Lake City, Utah. Active studies at this site cover conditions such as Neovascular Age-related Macular Degeneration, nAMD and Diabetic Macular Edema. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Retina Associates of Utah (8)

A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

for Neovascular Age-related Macular Degeneration

29 locations incl. Long Beach

Sponsor: Amgen

Sex: All·Age: 50+

Code: NCT07614776·Phase 3·Recruiting·Listed May 29, 2026

Apply to this trial

COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

for Diabetic Macular Edema

50 locations incl. Bakersfield

Sponsor: EyePoint Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT07449936·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

for Macular Degeneration

51 locations incl. Scottsdale

Sponsor: EyeBiotech Ltd.

Sex: All·Age: 50+

Code: NCT07440225·Phase 2, Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

for Geographic Atrophy Secondary to Age-related Macular Degeneration

78 locations incl. Gilbert

Sponsor: Apellis Pharmaceuticals, Inc.

Sex: All·Age: 60+

Code: NCT07215390·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

for Age-related Macular Degeneration (AMD)

140 locations incl. Chandler

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 50 - 85

Code: NCT06541704·Phase 3·Recruiting·Listed Aug 2024

Apply to this trial

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

for Neovascular Age-related Macular Degeneration

33 locations incl. Mesa

Sponsor: Genentech, Inc.

Sex: All·Age: 50+

Code: NCT04853251·Phase 4·Recruiting·Listed Apr 2021

Apply to this trial

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

for AMD

65 locations incl. Phoenix

Sponsor: AbbVie

Sex: All·Age: 50 - 89

Code: NCT05407636·Phase 3·Recruiting·Listed Jun 2022

Apply to this trial

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma

for Choroidal Melanoma

34 locations incl. La Jolla

Sponsor: Aura Biosciences

Sex: All·Age: 18+

Code: NCT06007690·Phase 3·Recruiting·Listed Aug 2023

Apply to this trial

More research sites in Salt Lake City

University of Utah (206 trials)
Huntsman Cancer Institute/University of Utah (71 trials)
Primary Children's Hospital (62 trials)
Huntsman Cancer Institute (61 trials)
Huntsman Cancer Institute, University of Utah (32 trials)
University of Utah Health (29 trials)
Huntsman Cancer Institute at University of Utah (19 trials)
University of Utah Hospital (19 trials)
University of Utah Sugarhouse Health Center (16 trials)
Huntsman Cancer Institute at the University of Utah (15 trials)

Explore more

Paid clinical trials in Salt Lake City, UT · Utah clinical trials